Results
|
21.
|
|
|
22.
|
|
|
23.
|
Lenalidomide in relapsed refractory myeloma patients: impact of previous response to bortezomib and thalidomide on treatment efficacy. Results of a medical need program in Belgium. [electronic resource] by
- Delforge, M
- Michiels, A
- Doyen, C
- Kentos, A
- Van Droogenbroeck, J
- Offner, F
- Bries, G
- Demuynck, H
- Vekemans, M C
- Meuleman, N
- Mineur, P O
- Ravoet, C
- Depryck, B
- Van de Velde, A
- Pierre, P
- Wu, K L
- Schots, R
Producer: 20120127
In:
Acta clinica Belgica vol. 66
Availability: No items available.
|
|
24.
|
The Belgian 2010 consensus recommendations for the treatment of multiple myeloma. [electronic resource] by
- Schots, R
- Delforge, M
- André, M
- Bries, G
- Caers, J
- Demuynck, H
- De Prijck, B
- De Samblanx, H
- Kentos, A
- Meuleman, N
- Offner, F
- Vekemans, M C
- Vande Broek, I
- Van Droogenbroeck, J
- Van de Vanelde, A
- Wu, K L
- Doyen, C
Producer: 20101210
In:
Acta clinica Belgica vol. 65
Availability: No items available.
|
|
25.
|
A randomized phase III study of carfilzomib vs low-dose corticosteroids with optional cyclophosphamide in relapsed and refractory multiple myeloma (FOCUS). [electronic resource] by
- Hájek, R
- Masszi, T
- Petrucci, M T
- Palumbo, A
- Rosiñol, L
- Nagler, A
- Yong, K L
- Oriol, A
- Minarik, J
- Pour, L
- Dimopoulos, M A
- Maisnar, V
- Rossi, D
- Kasparu, H
- Van Droogenbroeck, J
- Yehuda, D B
- Hardan, I
- Jenner, M
- Calbecka, M
- Dávid, M
- de la Rubia, J
- Drach, J
- Gasztonyi, Z
- Górnik, S
- Leleu, X
- Munder, M
- Offidani, M
- Zojer, N
- Rajangam, K
- Chang, Y-L
- San-Miguel, J F
- Ludwig, H
Producer: 20170830
In:
Leukemia vol. 31
Availability: No items available.
|